These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32357147)

  • 41. Detection of hepatic steatosis using the controlled attenuation parameter: a comparative study with liver biopsy.
    Yilmaz Y; Yesil A; Gerin F; Ergelen R; Akin H; Celikel ÇA; Imeryuz N
    Scand J Gastroenterol; 2014 May; 49(5):611-6. PubMed ID: 24611771
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prospective study comparing hepatic steatosis assessment by magnetic resonance imaging and four ultrasound methods in 105 successive patients.
    Collin R; Magnin B; Gaillard C; Nicolas C; Abergel A; Buchard B
    World J Gastroenterol; 2023 Jun; 29(22):3548-3560. PubMed ID: 37389233
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The prevalence of bright liver echo pattern in patients with chronic hepatitis C: correlation with steatosis and fibrosis.
    Loy M; Serra G; Chessa L
    J Ultrasound; 2016; 19(2):91-8. PubMed ID: 27298639
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ultrasound and FibroScan
    Salmi A; di Filippo L; Ferrari C; Frara S; Giustina A
    Endocrine; 2022 Nov; 78(2):262-269. PubMed ID: 35980569
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Liver Fat Quantification by Ultrasound in Children: A Prospective Study.
    D'Hondt A; Rubesova E; Xie H; Shamdasani V; Barth RA
    AJR Am J Roentgenol; 2021 Oct; 217(4):996-1006. PubMed ID: 33438457
    [No Abstract]   [Full Text] [Related]  

  • 46. Controlled attenuation parameter for the detection of hepatic steatosis in patients with chronic hepatitis B.
    Chen J; Wu D; Wang M; Chen E; Bai L; Liu C; Liao J; Tang H
    Infect Dis (Lond); 2016 Sep; 48(9):670-5. PubMed ID: 27241724
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment of transient elastography in diagnosing MAFLD and the early effects of sleeve gastrectomy on MAFLD among the Chinese population.
    Hu R; Wu B; Wang C; Wu Z; Zhang X; Chen X; Lu G; Yuan K
    Int J Surg; 2024 Apr; 110(4):2044-2054. PubMed ID: 38215263
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnostic Performance of 9 Quantitative Ultrasound Parameters for Detection and Classification of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease.
    Pirmoazen AM; Khurana A; Loening AM; Liang T; Shamdasani V; Xie H; El Kaffas A; Kamaya A
    Invest Radiol; 2022 Jan; 57(1):23-32. PubMed ID: 34049335
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The ultrasound-guided attenuation parameter is useful in quantification of hepatic steatosis in non-alcoholic fatty liver disease.
    Ogino Y; Wakui N; Nagai H; Igarashi Y
    JGH Open; 2021 Aug; 5(8):947-952. PubMed ID: 34386604
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantitative measurement of ultrasound attenuation and Hepato-Renal Index in Non-Alcoholic Fatty Liver Disease.
    von Volkmann HL; Havre RF; Løberg EM; Haaland T; Immervoll H; Haukeland JW; Hausken T; Gilja OH
    Med Ultrason; 2013 Mar; 15(1):16-22. PubMed ID: 23486619
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quantitative ultrasound radiofrequency data analysis for the assessment of hepatic steatosis using the controlled attenuation parameter as a reference standard.
    Jeon SK; Joo I; Kim SY; Jang JK; Park J; Park HS; Lee ES; Lee JM
    Ultrasonography; 2021 Jan; 40(1):136-146. PubMed ID: 32654442
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat Using a New Quantitative Ultrasound Technique.
    Lin SC; Heba E; Wolfson T; Ang B; Gamst A; Han A; Erdman JW; O'Brien WD; Andre MP; Sirlin CB; Loomba R
    Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1337-1345.e6. PubMed ID: 25478922
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Controlled attenuation parameter for the assessment of liver steatosis in comparison with liver histology: a single-centre real life experience.
    Baumeler S; Jochum W; Neuweiler J; Bergamin I; Semela D
    Swiss Med Wkly; 2019 Apr; 149():w20077. PubMed ID: 31026041
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatic steatosis, detected by hepatorenal index in ultrasonography, as a predictor of insulin resistance in obese subjects.
    Isaksen VT; Larsen MA; Goll R; Florholmen JR; Paulssen EJ
    BMC Obes; 2016; 3():39. PubMed ID: 27672441
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New diagnostic technique to evaluate hepatic steatosis using the attenuation coefficient on ultrasound B mode.
    Koizumi Y; Hirooka M; Tamaki N; Yada N; Nakashima O; Izumi N; Kudo M; Hiasa Y
    PLoS One; 2019; 14(8):e0221548. PubMed ID: 31454369
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Controlled attenuation parameter for the detection of steatosis severity in chronic liver disease: a meta-analysis of diagnostic accuracy.
    Shi KQ; Tang JZ; Zhu XL; Ying L; Li DW; Gao J; Fang YX; Li GL; Song YJ; Deng ZJ; Wu JM; Tang KF
    J Gastroenterol Hepatol; 2014 Jun; 29(6):1149-58. PubMed ID: 24476011
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acoustic Radiation Force Impulse and Conventional Ultrasound in the Prediction of Cirrhosis Complicating Fatty Liver: Does Body Mass Index Independently Alter the Results?
    Medellin A; Pridham G; Urbanski SJ; Jayakumar S; Wilson SR
    Ultrasound Med Biol; 2019 Dec; 45(12):3160-3171. PubMed ID: 31543356
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quantitative evaluation of hepatic steatosis using novel ultrasound technology normalized local variance (NLV) and its standard deviation with different ROIs in patients with metabolic-associated fatty liver disease: a pilot study.
    Zhao Y; Zhang C; Xu S; Zhang H; Wei S; Huang P; Zhang L; Wong YN; Xu W; Huang P
    Abdom Radiol (NY); 2022 Feb; 47(2):693-703. PubMed ID: 34958409
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Controlled attenuation parameter for noninvasive assessment of hepatic steatosis using Fibroscan®: validation in chronic hepatitis B.
    Mi YQ; Shi QY; Xu L; Shi RF; Liu YG; Li P; Shen F; Lu W; Fan JG
    Dig Dis Sci; 2015 Jan; 60(1):243-51. PubMed ID: 25194851
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reproducibility and accuracy of a pocket-size ultrasound device in assessing liver steatosis.
    Costantino A; Piagnani A; Caccia R; Sorge A; Maggioni M; Perbellini R; Donato F; D'Ambrosio R; Sed NPO; Valenti L; Prati D; Vecchi M; Lampertico P; Fraquelli M
    Dig Liver Dis; 2024 Jun; 56(6):1032-1038. PubMed ID: 38016894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.